- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities
My CPNP provides quick access to the most important features on cpnp.org.
You will see your important notices, and you will have direct access to your exams and other action items.
Log in now to see your personalized page.
Torres-Torres R, Sanchez-Dalmau BF. Treatment of acute optic neuritis and vision complaints in multiple sclerosis. Curr Treat Options Neurol. 2015;17(1):328. doi:10.1007/s11940-014-0328-z.
OPINION STATEMENT: Multiple sclerosis is an autoimmune demyelinating disorder of the nervous system, in which almost all patients develop some degree of visual impairment during the disease. Optic neuritis is the most common and known visual affection and may be the initial clinical disease manifestation, but visual complaints can have a wide variety of presentations and some of them can lead to clinical confusion. Most symptoms are the result of acute injury and subsequent axonal loss in the afferent and...
Pérez LP, González RS, Lázaro EB. Treatment of mood disorders in multiple sclerosis. Curr Treat Options Neurol. 2015;17(1):323. doi:10.1007/s11940-014-0323-4.
OPINION STATEMENT: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with a significant comorbidity with depressive disorders. Prevalence rates for major depressive disorder (MDD) range from 36 % to 54 % and the rate is around 22 % for adjustment disorders. Selective serotonin reuptake inhibitors (SSRIs) are considered well-tolerated first-line treatment. Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) are generally reserved for second-line...
If you have any questions, please contact us.